Approaching atrial septal defects in pulmonary hypertension

References

• Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D42-50
   PubMed Web of Science ®Google Scholar
• Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol 1999;20(3):195-9
   PubMed Web of Science ®Google Scholar
• Hanslik A, Pospisil U, Salzer-Muhar U, et al. Predictors of spontaneous closure of isolated secundum atrial septal defect in children: a longitudinal study. Pediatrics 2006;118(4):1560-5
   PubMed Web of Science ®Google Scholar
• Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet 2014;383(9932):1921-32
   PubMed Web of Science ®Google Scholar
• Rhee EK, Evangelista JK, Nigrin DJ, et al. Impact of anatomic closure on somatic growth among small, asymptomatic children with secundum atrial septal defect. Am J Cardiol 2000;85(12):1472-5
   PubMed Web of Science ®Google Scholar
• Ivy DD, Abman SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D117-26
   PubMed Web of Science ®Google Scholar
• Ivy DD, Feinstein JA, Humpl T, et al. Non-congenital heart disease associated pediatric pulmonary arterial hypertension. Prog Pediatr Cardiol 2009;27(1-2):13-23
   PubMedGoogle Scholar
• van Loon RL, Roofthooft MT, Hillege HL, et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 2011;124(16):1755-64
   PubMed Web of Science ®Google Scholar
• Ferdman DJ, Brady D, Rosenzweig EB. Common atrium and pulmonary vascular disease. Pediatr Cardiol 2011;32(5):595-8
   PubMed Web of Science ®Google Scholar
• Lammers A, Hager A, Eicken A, et al. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg 2005;129(6):1353-7
   PubMed Web of Science ®Google Scholar
• Goetschmann S, Dibernardo S, Steinmann H, et al. Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy. Am J Cardiol 2008;102(3):340-2
   PubMed Web of Science ®Google Scholar
• Thomas VC, Vincent R, Raviele A, et al. Transcatheter closure of secundum atrial septal defect in infants less than 12 months of age improves symptoms of chronic lung disease. Congenit Heart Dis 2012;7(3):204-11
   PubMed Web of Science ®Google Scholar
• Diab KA, Cao QL, Bacha EA, et al. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg 2007;134(4):960-6
   PubMed Web of Science ®Google Scholar
• Giglia TM, Humpl T. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation? Pediatr Crit Care Med 2010;11(2 Suppl):S57-69
   Google Scholar
• Lopes AA, Barst RJ, Haworth SG, et al. Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? consensus statement from the congenital heart disease and pediatric task forces, pulmonary vascular research institute (PVRI). Pulmonary Circulation 2014;4(2):330-41
   PubMed Web of Science ®Google Scholar
• Lindsey JB, Hillis LD. Clinical update: atrial septal defect in adults. Lancet 2007;369(9569):1244-6
   PubMed Web of Science ®Google Scholar
• Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 2007;120(2):198-204
   PubMed Web of Science ®Google Scholar
• Lowe BS, Therrien J, Ionescu-Ittu R, et al. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol 2011;58(5):538-46
   PubMed Web of Science ®Google Scholar
• Steele PM, Fuster V, Cohen M, et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation 1987;76(5):1037-42
   PubMed Web of Science ®Google Scholar
• Engelfriet PM, Duffels MG, Moller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2007;93(6):682-7
   PubMed Web of Science ®Google Scholar
• Chemla D, Humbert M, Sitbon O, et al. Systolic and mean pulmonary artery pressures: are they interchangeable in patients with pulmonary hypertension? Chest 2015;147(4):943-50
   PubMed Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D34-41
   PubMed Web of Science ®Google Scholar
• Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114(15):1645-53
   PubMed Web of Science ®Google Scholar
• Jategaonkar S, Scholtz W, Schmidt H, et al. Percutaneous closure of atrial septal defects: echocardiographic and functional results in patients older than 60 years. Circ Cardiovasc Interv 2009;2(2):85-9
   PubMed Web of Science ®Google Scholar
• Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 2014;35(11):716-24
   PubMed Web of Science ®Google Scholar
• Rabinovitch M, Keane JF, Norwood WI, et al. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 1984;69(4):655-67
   PubMed Web of Science ®Google Scholar
• Berger RM. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 2000;21(1):17-27
   PubMed Web of Science ®Google Scholar
• Beghetti M, Galie N, Bonnet D. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality? Congenit Heart Dis 2012;7(1):3-11
   PubMed Web of Science ®Google Scholar
• Balzer DT, Kort HW, Day RW, et al. Inhaled nitric oxid as preoperative test (INOP Test I). Circulation 2002;106(Suppl 1):I76-81
   Google Scholar
• D’Alto M, Romeo E, Argiento P, et al. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure. Int J Cardiol 2013;168(4):3797-801
   PubMed Web of Science ®Google Scholar
• Lopes AA, O’Leary PW. Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease. Cardiol Young 2009;19(5):431-5
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31(23):2915-57
   PubMed Web of Science ®Google Scholar
• Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 2008;94(9):1189-93
   PubMed Web of Science ®Google Scholar
• Yong G, Khairy P, De Guise P, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2009;2(5):455-62
   PubMed Web of Science ®Google Scholar
• Silversides CK, Marelli A, Beauchesne L, et al. Canadian cardiovascular society 2009 Consensus conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol 2010;26(3):143-50
   PubMed Web of Science ®Google Scholar
• Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008;118(23):e714-833
   PubMed Web of Science ®Google Scholar
• Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115(8):1039-50
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Inuzuka R, Goletto S, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010;121(1):20-5
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Zafar M, McLaughlin PR, et al. Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy. Int J Cardiol 2006;110(1):104-7
   PubMed Web of Science ®Google Scholar
• Frost AE, Quinones MA, Zoghbi WA, et al. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 2005;24(4):501-3
   PubMed Web of Science ®Google Scholar
• Hirabayashi A, Miyaji K, Akagi T. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension. Catheter Cardiovasc Interv 2009;73(5):688-91
   PubMed Web of Science ®Google Scholar
• Bradley EA, Chakinala M, Billadello JJ. Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure. Am J Cardiol 2013;112(9):1471-6
   PubMed Web of Science ®Google Scholar
• Hoetzenecker K, Ankersmit HJ, Bonderman D, et al. Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report. J Thorac Cardiovasc Surg 2009;137(3):760-1
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 2008;129(2):163-71
   PubMed Web of Science ®Google Scholar
• Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S43-54
   PubMed Web of Science ®Google Scholar